Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Omnipaque 240 (iohexol)
- sodium iodide i-123
Interactions between your drugs
iohexol sodium iodide I-123
Applies to: Omnipaque 240 (iohexol), sodium iodide i-123
ADJUST DOSING INTERVAL: Iodine-containing products may affect the pharmacokinetics, pharmacodynamics, and/or diagnostic results of radioiodides. These effects may last up to 8 weeks.
MANAGEMENT: Iodine preparations including expectorants, vitamins, topicals, and intravascular iodine-containing contrast media should be withheld for at least 2 to 4 weeks and possibly longer, and cholecystographic agents should be withheld for more than 4 weeks, prior to administration of sodium iodide I-131 or I-123.
References (4)
- (2001) "Product Information. Visipaque (iodixanol)." Nycomed Inc
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- (2022) "Product Information. Sodium Iodide I-123 (sodium iodide I-123)." GE Healthcare
- Cerner Multum, Inc. "Australian Product Information."
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to consumer interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Omnipaque 350
Omnipaque 350 is used for angiocardiography, aortography, arthrography, body imaging, cerebral ...
Omnipaque 300
Omnipaque 300 is used for angiocardiography, aortography, arthrography, body imaging, cerebral ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Visipaque
Visipaque is used for aortography, cerebral arteriography, computed tomography, coronary ...
Omnipaque 140
Omnipaque 140 is used for angiocardiography, aortography, arthrography, body imaging, cerebral ...
Magnevist
Magnevist (gadopentetate dimeglumine) is a contrast agent used to help diagnose certain disorders ...
Gadavist
Gadavist (gadobutrol) is a contrast agent used in MRI's to help diagnose certain disorders of the ...
Dotarem
Dotarem (gadoterate meglumine) is a gadolinium-based contrast agent used in magnetic resonance ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.